Treatment Information

Back

Breast Cancer treatment details. Chemotherapy.

Indiana University Medical Center, Indianapolis, Indiana, United States.

Survival: monthsCountry:United States
Toxiciy Grade:5City/State/Province:Indianapolis, Indiana
Treatments:ChemotherapyHospital:Indiana University Medical Center
Drugs:Journal:Link
Date:Feb 2003

Description:

Patients: This Phase III trial involved 731 patients with metastatic breast cancer. Patients were divided into three groups: Group A contained 245 patients, Group B contained 242 patients, and Group C contained 244 patients.

Treatment: Patients in Group A were administered the drug doxorubicin. Patients in Group B were administered the drug paclitaxel (taxol). Patients in Group C were administered the drugs – doxorubicin and paclitaxel.

Toxicity: 1.6% of patients in Group B (i.e. 4 patients) experienced “lethal toxicity.” Grade 3-4 toxicities included hematologic, infection, cardiac complications, neurologic complications, vomiting, diarrhea, and stomatitis.

Results: Median overall survival for patients in Group B was 22.5 months.

Correspondence: George W. Sledge, MD




Back